When innovation moves faster than policy, the path to market calls for creative approaches. Tammie Wahaus, CEO of ELIAS Animal Health, shares how her team advances pivotal trials, adapts human health technologies, and keeps development on track as regulatory expectations continue to evolve.
Session Topics:
Biopharma
USDA
Oncology
Canine
Regulation
Immunotherapy
Treatment
Companion
Milestone - Shifting Regulatory Landscape
Speaker(s):
Tammie Wahaus
Chief Executive Officer
ELIAS Animal Health
Time:
1:55pm - 2:15pm
Agenda Track No.:
Track 2
Summary:
Session Will be Recorded - Attend live or Watch On-Demand
Session Type:
General Session (Presentation)